Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2025-12-24 @ 3:40 PM
NCT ID:
NCT02321592
Brief Summary:
The study is designed
* to demonstrate efficacy of AFM13 with an optimized treatment schedule
* to decide whether AFM13 warrants further investigation in a phase III clinical trial
Study:
NCT02321592
Study Brief:
Protocol Section:
NCT02321592